Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 12, 2008

BG Medicine to Mine Danish Population Research for Cardiovascular Biomarkers

  • BG Medicine and Copenhagen General Population Study have partnered to discover and validate cardiovascular biomarkers including those predictive of rupture of atherosclerotic plaque and myocardial infarction. The planned research, which will be conducted as part of BG Medicine’s High Risk Plaque (HRP) Initiative, will apply the company’s proteomic and metabolomic discovery platform capabilities.

    The HRP Initiative is an industry alliance that aims to discover and develop improved techniques for identifying individuals at risk for heart attacks and the advancement of methods to monitor cardiac disease progression and response to treatment. The HRP Initiative expects to dedicate a total of $30 million in funding toward this research over four years.

    The work is expected to commence in March on samples obtained from various Copenhagen cohort studies including the Copenhagen City Heart Study and the ongoing Copenhagen General Population Study and will be conducted in multiple phases.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »